• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4669527)   Today's Articles (5725)   Subscriber (51804)
For: Wang N. Cytogenetics and molecular genetics of ovarian cancer. Am J Med Genet 2002;115:157-63. [PMID: 12407696 DOI: 10.1002/ajmg.10695] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Number Cited by Other Article(s)
1
Rowswell-Turner RB, Singh RK, Urh A, Yano N, Kim KK, Khazan N, Pandita R, Sivagnanalingam U, Hovanesian V, James NE, Ribeiro JR, Kadambi S, Linehan DC, Moore RG. HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression. THE JOURNAL OF IMMUNOLOGY 2021;206:2478-2488. [PMID: 33903172 DOI: 10.4049/jimmunol.2000281] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/13/2020] [Accepted: 03/08/2021] [Indexed: 01/18/2023]
2
Rosen DG, Zhang Z, Shan W, Liu J. Morphological and molecular basis of ovarian serous carcinoma. J Biomed Res 2013;24:257-63. [PMID: 23554638 PMCID: PMC3596590 DOI: 10.1016/s1674-8301(10)60036-x] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2010] [Indexed: 12/17/2022]  Open
3
Caserta D, Benkhalifa M, Baldi M, Fiorentino F, Qumsiyeh M, Moscarini M. Genome profiling of ovarian adenocarcinomas using pangenomic BACs microarray comparative genomic hybridization. Mol Cytogenet 2008;1:10. [PMID: 18492273 PMCID: PMC2435107 DOI: 10.1186/1755-8166-1-10] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2008] [Accepted: 05/20/2008] [Indexed: 02/03/2023]  Open
4
Monoranu CM, Huang B, Zangen ILV, Rutkowski S, Vince GH, Gerber NU, Puppe B, Roggendorf W. Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas. ACTA ACUST UNITED AC 2008;182:18-26. [PMID: 18328946 DOI: 10.1016/j.cancergencyto.2007.12.008] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2007] [Revised: 11/29/2007] [Accepted: 12/10/2007] [Indexed: 02/08/2023]
5
Bignotti E, Tassi RA, Calza S, Ravaggi A, Bandiera E, Rossi E, Donzelli C, Pasinetti B, Pecorelli S, Santin AD. Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes. Am J Obstet Gynecol 2007;196:245.e1-11. [PMID: 17346539 DOI: 10.1016/j.ajog.2006.10.874] [Citation(s) in RCA: 77] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2006] [Revised: 08/28/2006] [Accepted: 10/11/2006] [Indexed: 11/30/2022]
6
Feng Q, Yu M, Kiviat NB. Molecular biomarkers for cancer detection in blood and bodily fluids. Crit Rev Clin Lab Sci 2007;43:497-560. [PMID: 17050080 DOI: 10.1080/10408360600922632] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
7
Gamzatova Z, Villabona L, Dahlgren L, Dalianis T, Nillson B, Bergfeldt K, Masucci GV. Human leucocyte antigen (HLA) A2 as a negative clinical prognostic factor in patients with advanced ovarian cancer. Gynecol Oncol 2006;103:145-50. [PMID: 16542716 DOI: 10.1016/j.ygyno.2006.02.004] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2005] [Revised: 01/24/2006] [Accepted: 02/03/2006] [Indexed: 12/12/2022]
8
Panani AD, Roussos C. Non-random structural chromosomal changes in ovarian cancer: i(5p) a novel recurrent abnormality. Cancer Lett 2006;235:130-5. [PMID: 15927360 DOI: 10.1016/j.canlet.2005.04.010] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2005] [Revised: 04/08/2005] [Accepted: 04/11/2005] [Indexed: 01/02/2023]
9
Cheng KW, Lahad JP, Mills GB. Analysis of Molecular Aberrations in Ovarian Cancer Allows Novel Target Identification. JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA 2004;26:461-74. [PMID: 15151733 DOI: 10.1016/s1701-2163(16)30657-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
10
Lee JM. The role of protein elongation factor eEF1A2 in ovarian cancer. Reprod Biol Endocrinol 2003;1:69. [PMID: 14588074 PMCID: PMC239897 DOI: 10.1186/1477-7827-1-69] [Citation(s) in RCA: 40] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/30/2003] [Accepted: 10/07/2003] [Indexed: 01/01/2023]  Open
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA